Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2200063624Phase 3Not yet recruiting
Phase 3, randomised trial of Shizhen formula in atopic dermatitis (AD) (2 arms), sponsored by Shuguang Hospital. Primary endpoint: Clinical efficacy. Planned start Sep 2022; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2200063624.